We are very excited to announce that our offer for preclinical cancer models are now included in the Personnal Shopper Service of Repositive! They will also soon be searchable on their Cancer Model Platform!
Elsa Kress will be at the BioFIT Event in Lille, France, on the 4th and 5th of December. Please don’t hesitate to contact us for a meeting! You can fill the form below and we will get back you.
Elsa Kress, our Study Director has been invited to participate to the Workshop Animal Models at the 1st Antibody Club in Paris, France, on November 8th and 9th. Do not hesitate do contact us for a rendez-vous to discuss your […]
We are proud to announce that the publication of our CIFRE PhD candidate Chloé Grasselly, on the combination of Chemotherapy and Immune Checkpoint Inhibitors is now published in Frontiers in Immunology!
The 11th Edition of the Rendez-vous Carnot will occur in Lyon on October 17th and 18th 2018. Antineo is proud to announce that our offer of In vivo development of original tumour models for resistance to therapies in immuno-oncology has […]
We will participate to the AFSSI Connexion meeting in Marseille, France on July 2nd and 3rd. Elsa Kress will present our offer during the pitchs session at the AFSSI Village. Please don’t hesitate to contact us for a meeting! You […]
We are extremely proud and excited to announce that our abstract has been selected for a presentation by the prestigious AIS Scientific Committee!
Elsa Kress will represent Antineo at the 6th Antibody Industrial Symposium in Montpellier, France, June 25th and 26th. Please don’t hesitate to contact us for a meeting! You can fill the form below and we will get back you.
Elsa Kress will be at the Meet 2 Win Oncology Business Convention in Bordeaux, France, on the 17th and 18th of May. Please don’t hesitate to contact us for a meeting! You can fill the form below and we will […]
Antineo has been invited to present its offer of services at the day for Développement Préclinique des Immunothérapies organised by Mabdesign and Lyonbiopole, on April 24th, in Lyon, France